CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 6 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,679,000 | +492.7% | 23,686 | +424.4% | 0.00% | – |
| Q1 2017 | $452,000 | -7.0% | 4,517 | 0.0% | 0.00% | – |
| Q4 2016 | $486,000 | -13.2% | 4,517 | +0.4% | 0.00% | – |
| Q3 2016 | $560,000 | +17.2% | 4,500 | 0.0% | 0.00% | – |
| Q2 2016 | $478,000 | -7.2% | 4,500 | 0.0% | 0.00% | – |
| Q1 2016 | $515,000 | +3.2% | 4,500 | +28.6% | 0.00% | – |
| Q4 2015 | $499,000 | -20.5% | 3,500 | -50.0% | 0.00% | – |
| Q3 2015 | $628,000 | – | 7,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
| WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
| Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
| RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
| INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
| Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
| Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
| Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |